v3.26.1
Equity Incentive Plans
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Equity Incentive Plans

Note 11. Equity Incentive Plans

 

The Company’s 2021 Equity Incentive Plan (the “2021 Plan”) was originally approved by the Company’s stockholders on October 1, 2021, and has subsequently been amended, most recently pursuant to Amendment No. 3 approved by stockholders on July 23, 2025, to increase the number of shares authorized for issuance under the 2021 Plan to 2.0 million shares. The purpose of the 2021 Plan is to attract and retain directors, consultants, officers and other key employees of the Company and its subsidiaries and to provide to such persons incentives and rewards for superior performance. The 2021 Plan is administered by the Compensation and Management Resources Committee of the Board and has a term of ten years. The 2021 Plan awards may be in the form of stock options (which may be incentive stock options or nonqualified stock options), stock appreciation rights (“SARs”), restricted shares, RSUs, and other share-based awards. As of December 31, 2025, there were approximately 2.0 million shares remaining available for future issuance.

 

In addition, on March 24, 2023, the Board approved an employee stock purchase plan (“FGF ESPP Plan”) whereby qualifying employees can choose each year to have up to 5% of their annual base earnings withheld to purchase the Company’s common shares in the open market. The Company matches 100% of the employee’s contribution amount after thirty days of employment.

 

Total stock-based compensation expense for the years ended December 31, 2025 and December 31, 2024 was approximately $7.8 million and $1.6 million, respectively. The increase in stock-based compensation expense in the current period is primarily related to the issuance of warrants in connection with the Private Placement Offering. See Note 12 for additional details. Effective July 31, 2025, the Compensation and Management Resources Committee of the Board of Directors also approved the acceleration of all unvested restricted stock units.

 

As of December 31, 2025, total unrecognized stock compensation expense of approximately $18 thousand remained, all of which related to stock options, and will be recognized through June 2028. Stock compensation expense has been reflected in the Company’s financial statements as part of general and administrative expense.

 

Restricted Stock Units

 

The following table summarizes RSU activity for the year ended December 31, 2025:

 

Restricted Stock Units 

Number of

Units

  

Weighted

Average Grant Date Fair Value

 
Non-vested units, December 31, 2024   6,254   $247.12 
Granted   4,116    84.90 
Vested   (10,157)   181.45 
Forfeited   (213)   245.00 
Non-vested units, December 31, 2025   -   $- 

 

In May 2025, the Company granted a total of 4,116 RSUs to the members of its Board of Directors pursuant to the Company’s director compensation policy.

 

 

Stock Options

 

The following table summarizes activity for stock options issued for the year ended December 31, 2025:

 

Common Stock Options  Shares   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term (yrs)   Weighted Average Grant Date Fair Value   Aggregate Intrinsic Value 
Outstanding, December 31, 2024   5,358   $357.20    5.9   $177.2   $- 
Granted   -    -    -    -    - 
Exercised   -    -    -    -    - 
Expired   (1,244)   339.85    -    163.50    - 
Forfeited   (914)   251.40    -    149.15    - 
Outstanding, December 31, 2025   3,200   $394.05    4.0   $190.50   $- 
Exercisable, December 31, 2025   1,944   $396.05    3.3   $172.45   $-